Synedica Tirzepatide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Mounjaro,” tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1 and GIP receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.
The Synedica Tirzepatide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.
Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.
Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.
Always consult your doctor, nurse or pharmacist before using any new medication.
Synedica Tirzepatide® 40mg Injection Pen Kit is available at selected pharmacies across Germany, and potentially free for German citizens who qualify under Gesetzliche Krankenversicherung.
Synedica Tirzepatide® Injection Pen Kit is the world's most advanced weight loss solution. Commonly known as “Mounjaro,” tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1 and GIP, natural hormones that makes humans feel full from eating much smaller portions of food. The Synedica Tirzepatide® Injection Pen Kit will last the average new user 12 weeks.
By feeling full through the day users can experience fast and lasting fat loss without the normal hunger cravings of a traditional diet.
Most common side effects are nausea, jaw ache, and depression. For a full list of common and uncommon potential side effects see the booklet enclosed.
1 pen, 12 disposable 32g 4mm needles and an instruction booklet.
One kit which normally last 12 weeks for new users to semaglutide costs 400 euros from private pharmacies but is available free under certain employer health policies and for German citizens who qualify under Gesetzliche Krankenversicherung.
Currently Synedica Tirzepatide® Injection Pen Kits are only available with a prescription in Germany from private clinics.
All new users should always start with semaglutide, then if necessary switch to tirzepatide and then retatrutide. The body will naturally build up an tolerance over time which is why the dose must be increased. Semaglutide effects 1 receptor in the body, but tirzepatide effect 2 receptors will be be very effective in users in a small dose who have built up a tolerance to semaglutide on the higher doses. Retatrutide effects 3 receptors so is perfect for users if a tolerance to the higher doses of tirzepatide has developed.
